Skip to main content
. 2020 Jan 8;10:48. doi: 10.1038/s41598-019-56880-3

Figure 4.

Figure 4

Palmitate and cholinergic agonists modulate the inflammatory pathway and insulin resistance in hepatocyte lineage. α7nAChR (a), pJNK (b) evaluated by Western blot (WB), and IL-6 (c) and TNF-α (d) mRNA levels evaluated by RT-PCR, and pAKT (e) evaluated by WB in hepatoma cells lineage, Hepa-1c1c7 (ATCC® CRL-2026™), after treatment with palmitate (500 µM) for 3 hours and nicotine (1 µM) or PNU (1 µM) for 15 minutes, or insulin (100 nM) for 10 minutes. The percent expression of control (GAPDH) is shown (means ± SD, n = 3 independent experiments with triplicate each). Statistical significance was analysed by ANOVA and Bonferroni post-hoc tests (*p < 0.05, **p < 0.01, ***p < 0.001).